Home
Solution
Impact
R&D
Science
Publications
STEP study
Xinnate’s Expanded Access Policy
About
Team and Board
News and Events
All News
All Events
All Press Releases
Contact
Version 2
Home
News
Xinnate secures 100 million SEK in financing and applies for a patent for the treatment of Epidermolysis Bullosa
Version 2
